| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.23 | 0.002 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |